Michigan Cancer Research Consortium
Michigan Cancer Research Consortium List of component institutions
ABOUT MCRC-CCOP Active Clinical Trials About Clinical Trials Cancer Rsearch Info Resources & Links Member Area
Cancer Treatment and Symptom Management Trials Cancer Prevention and Control Trials
Active Clinical Trials > Cancer Treatment and Symptom Management Trials

Active Clinical Trials: Other Blood Disorders

>> Go back to the list of categories
 
ProtocolTitle
SWOG-8819
(Hematology- Miscellaneous)		Central Lymphoma Repository Tissue Procurement Protocol (951)
  • Eligibility: click to view information

    For patients registered to a currently active Southwest Oncology Group-coordinated treatment protocol for previously untreated non-Hodgkin's lymphoma.



SWOG-S0309
(Hematology- Miscellaneous)		Myeloma Specimen Repository Protocol, Ancillary (1039)
  • Eligibility: click to view information

    STUDY DRUG: None
    1) Pts currently registered on SWOG or Intergroup treatment studies for multiple myeloma (MM), smoldering myeloma, Waldenstorm's macroglobulinemia (WM), monoclonal gammopathy of undetermined significance (MGUS) or amyloidosis (AL).
    2) Pts already enrolled on active SWOG teatment protocols.

[ back to top ]
Contact MCRC
Site Index
Site Feedback
View video Interview of Dr. Philip Stella
 
Home | About MCRC-CCOP | Active Clinical Trials | About Clinical Trials | Cancer Research Info | Resources & Links
Member Area | Contact MCRC | Site Index | Site Feedback | Site Credit
 
© 2010 MCRC. All rights reserved.